catalog number :
MBS690156
products full name :
Anti-Human BAFF
products short name :
[BAFF]
products name syn :
[Monoclonal antibody anti-human BAFF]
other names :
[type 2 lactosamine alpha-2,3-sialyltransferase isoform 3; Type 2 lactosamine alpha-2,3-sialyltransferase; type 2 lactosamine alpha-2,3-sialyltransferase; alpha2,3-sialyltransferase ST3Gal VI; sialyltransferase 10 (alpha-2,3-sialyltransferase VI); CMP-NeuAc:beta-galactoside alpha-2,3-sialyltransferase VI; ST3 beta-galactoside alpha-2,3-sialyltransferase 6; CMP-NeuAc:beta-galactoside alpha-2,3-sialyltransferase VI; ST3Gal VI; ST3GalVI; Sialyltransferase 10]
products gene name :
[BAFF]
other gene names :
[ST3GAL6; ST3GAL6; SIAT10; ST3GALVI; SIAT10; ST3GalVI]
uniprot entry name :
SIA10_HUMAN
purity :
Protein G chromatography
storage stability :
Stability: Lyophilized antibody is stable at room temperature for up to 1 month. The reconstituted antibody is stable for at least 2 weeks at 2-8 degree C. Frozen aliquots are stable for at least 6 months when stored at -20 degree C.
tested application :
ELISA; Western Blot (WB)
app notes :
ELISA: . In a Sandwich ELISA (assuming 100 ?l/well), a concentration of 5-6 ug/ml of this antibody will detect at least 1000 pg/ml of recombinant Human BAFF when used in conjunction with an appropriate conjugated secondary antibody as detection system. Western Blot:. To detect hBAFF by Western Blot analysis this antibody can be used at a concentration of 0.25 - 0.50 ug/ml. When used in conjunction with compatible secondary reagents the detection limit for recombinant hBAFF is 1 - 2 ng/lane, under reducing and non-reducing conditions.
other info1 :
Immunogen: highly pure (>98%) recombinant human BAFF. Antibody Generation: Monoclonal antibodies were produced in BALB/c mice using recombinant human BAFF as the immunizing antigen. This IgG1/K antibody was purified from ascites fluid on a protein A chromatography column. Protein RefSeq: NP_006564.1. Uniprot ID: Q9Y274. mRNA RefSeq: NM_006573.4
other info2 :
Buffer: PBS. Reconstitution buffer: water. Reconstitution: Centrifuge vial prior to opening. Reconstitute the antibody in sterile water to a concentration of 0.1 - 1.0 mg/ml.
products description :
BAFF, also known as Blymphocyte stimulator (BLyS), TNFand APO-Lrelated leukocyte expressed ligand 1 (TALL1), and TNF homolog that activates apoptosis, NFKB and JNK (THANK), is a TNF ligand superfamily member and has been designated TNFSF13B.
ncbi acc num :
NP_001258074.1
ncbi gb acc num :
NM_001271145.1
ncbi mol weight :
38,214 Da
ncbi pathways :
Disease Pathway (530764); Glycosaminoglycan Metabolism Pathway (645297); Glycosphingolipid Biosynthesis - Lacto And Neolacto Series Pathway (82995); Glycosphingolipid Biosynthesis - Lacto And Neolacto Series Pathway (370); Keratan Sulfate Biosynthesis Pathway (645302); Keratan Sulfate/keratin Metabolism Pathway (645301); MPS I - Hurler Syndrome Pathway (685537); MPS II - Hunter Syndrome Pathway (685538); MPS IIIA - Sanfilippo Syndrome A Pathway (685539); MPS IIIB - Sanfilippo Syndrome B Pathway (685540)
ncbi summary :
The protein encoded by this gene is a member of the sialyltransferase family. Members of this family are enzymes that transfer sialic acid from the activated cytidine 5'-monophospho-N-acetylneuraminic acid to terminal positions on sialylated glycolipids (gangliosides) or to the N- or O-linked sugar chains of glycoproteins. This protein has high specificity for neolactotetraosylceramide and neolactohexaosylceramide as glycolipid substrates and may contribute to the formation of selectin ligands and sialyl Lewis X, a carbohydrate important for cell-to-cell recognition and a blood group antigen. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Sep 2012]
uniprot summary :
Function: Involved in the synthesis of sialyl-paragloboside, a precursor of sialyl-Lewis X determinant. Has a alpha-2,3-sialyltransferase activity toward Gal-beta1,4-GlcNAc structure on glycoproteins and glycolipids. Has a restricted substrate specificity, it utilizes Gal-beta1,4-GlcNAc on glycoproteins, and neolactotetraosylceramide and neolactohexaosylceramide, but not lactotetraosylceramide, lactosylceramide or asialo-GM1. Subcellular location: Golgi apparatus membrane; Single-pass type II membrane protein . Potential. Tissue specificity: Ubiquitous. Sequence similarities: Belongs to the glycosyltransferase 29 family.